Cargando…
Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance
One of the greatest obstacles to current cancer treatment efforts is the development of drug resistance by tumors. Despite recent advances in diagnostic practices and surgical interventions, many neoplasms demonstrate poor response to adjuvant or neoadjuvant radiation and chemotherapy. As a result,...
Autores principales: | Denduluri, Sahitya K., Idowu, Olumuyiwa, Wang, Zhongliang, Liao, Zhan, Yan, Zhengjian, Mohammed, Maryam K., Ye, Jixing, Wei, Qiang, Wang, Jing, Zhao, Lianggong, Luu, Hue H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431759/ https://www.ncbi.nlm.nih.gov/pubmed/25984556 http://dx.doi.org/10.1016/j.gendis.2014.10.004 |
Ejemplares similares
-
Molecular pathogenesis and therapeutic strategies of human osteosarcoma
por: Denduluri, Sahitya K, et al.
Publicado: (2016) -
Wnt versus Hippo: A balanced act or dynamic duo?
por: Wang, Zhongliang, et al.
Publicado: (2014) -
Insider information: Testing cancer drug sensitivity for personalized therapy
por: Wang, Jing, et al.
Publicado: (2015) -
Bone Morphogenetic Protein (BMP) signaling in development and human diseases
por: Wang, Richard N., et al.
Publicado: (2014) -
TqPCR: A Touchdown qPCR Assay with Significantly Improved Detection Sensitivity and Amplification Efficiency of SYBR Green qPCR
por: Zhang, Qian, et al.
Publicado: (2015)